Advertisement
Screener

OTC:VICP | Increase (Decrease) in Accrued Liabilities | Vicapsys Life Sciences, Inc.

0.5 / 5 stars · 13/120 Roast Me

Vicapsys Life Sciences, Inc. Increase (Decrease) in Accrued Liabilities

Discontinued › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2021-09-17

  • Vicapsys Life Sciences, Inc. increase (decrease) in accrued liabilities for the quarter ending 2020-12-31 was $0.00.
  • Vicapsys Life Sciences, Inc. increase (decrease) in accrued liabilities for the quarter ending 2020-09-30 was $35.45K.
  • Vicapsys Life Sciences, Inc. increase (decrease) in accrued liabilities for the quarter ending 2020-06-30 was $63.45K.
  • Vicapsys Life Sciences, Inc. increase (decrease) in accrued liabilities for the quarter ending 2020-03-31 was $16.41K.
  • Vicapsys Life Sciences, Inc. increase (decrease) in accrued liabilities for fiscal 2020 was $115.31K.
Period endIncrease (Decrease) in Accrued Liabilities 3 monthIncrease (Decrease) in Accrued Liabilities 6 monthIncrease (Decrease) in Accrued Liabilities 9 monthIncrease (Decrease) in Accrued Liabilities 12 month
2020-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-17
$35.45K
derived: sum of 2 quarters · filed 2021-09-17
$98.90K
derived: sum of 3 quarters · filed 2021-09-17
$115.31K
10-K · filed 2021-09-17
2020-09-30$35.45K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-09-13
$98.90K
derived: sum of 2 quarters · filed 2021-09-13
$115.31K
10-Q · filed 2021-09-13
2020-06-30$63.45K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-09-09
$79.86K
10-Q · filed 2021-09-09
2020-03-31$16.41K
10-Q · filed 2020-05-15